The prevention and treatment of intrauterine growth restriction

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 23, Issue 6, 2009, Pages 795-807

  Grivell, Rosalie ^a   Dodd, Jodie ^a   Robinson, Jeffrey ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

foetal growth restriction; pregnancy complications; pregnancy outcome; primary prevention

Indexed keywords

ACETYLSALICYLIC ACID; AMINO ACID; ANTIMALARIAL AGENT; ANTIOXIDANT; ANTIRETROVIRUS AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CALCIUM; CORTICOSTEROID; FLUNARIZINE; FOLIC ACID; GLUCOSE; INSECTICIDE; IODINE; IRON; LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM; MAGNESIUM SULFATE; OXYGEN; PLACEBO; PYRIDOXINE; ZINC;

ALCOHOL WITHDRAWAL; ANEMIA; ARTICLE; BED NET; BED REST; BODY MASS; CALORIC INTAKE; CEREBRAL PALSY; CESAREAN SECTION; CHILD HEALTH; CHILDBIRTH; CLINICAL TRIAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; EXERCISE; FAMILY PLANNING; FETUS; FIRST TRIMESTER PREGNANCY; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; IODINE DEFICIENCY; LIFESTYLE MODIFICATION; LOW BIRTH WEIGHT; MALARIA FALCIPARUM; MATERNAL NUTRITION; MATERNAL WELFARE; MOTOR DYSFUNCTION; NEURAL TUBE DEFECT; NEWBORN MORBIDITY; NUTRITIONAL STATUS; OXIDATIVE STRESS; PLACENTA PREVIA; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREMATURITY; PRENATAL CARE; PRIORITY JOURNAL; PROTEIN INTAKE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMALL FOR DATE INFANT; SMOKING CESSATION; SOLUTIO PLACENTAE; SUBSTANCE ABUSE; THROMBOPHILIA; TRISOMY 21; WEIGHT GAIN; ZINC DEFICIENCY; DELIVERY; ENVIRONMENTAL EXPOSURE; FEMALE; FETAL GROWTH RETARDATION; INFERTILITY THERAPY; MATERNAL AGE; MATERNAL CARE; MULTIPLE PREGNANCY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PROCEDURES;

BODY MASS INDEX; DELIVERY, OBSTETRIC; DIETARY SUPPLEMENTS; FEMALE; FETAL GROWTH RETARDATION; HUMANS; MATERNAL AGE; MATERNAL EXPOSURE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; OXYGEN; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY, MULTIPLE; REPRODUCTIVE TECHNIQUES, ASSISTED; WEIGHT GAIN;

EID: 71849112578     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2009.06.004     Document Type: Article

References (89)

1. Simpson A.R. Introduction. In: Budin P. (Ed). The nursling London (1907), The Caxton Publishing Co
2. WHO. Obesity: preventing and managing the global epidemic (2000), World Health Organisation, Geneva
3. Wigglesworth J.S. Pathological and experimental aspects of foetal growth retardation. Proc R Soc Med 60 9 (1967 Sep) 879-881
4. Economides D.L., and Nicolaides K.H. Cordocentesis in the investigation of fetal oxygenation and metabolism. In: Chervenak F.A., Isaacson G.C., and Campbell S. (Eds). Ultrasound in obstetrics and gynecology (1993), Little, Brown and Company, Boston
5. Baschat A.A. Fetal growth disorders. High risk pregnancy management options (2006), Saunders, Philadelphia
6. Conti J., Abraham S., and Taylor A. Eating behavior and pregnancy outcome. J Psychosom Res 44 (1998) 465-477
7. Baschat A.A., and Harman C.R. Antenatal assessment of the growth restricted fetus. Curr Opin Obstet Gynecol 13 (2001) 161-168
8. Gardosi J., Mul T., Mongelli M., et al. Analysis of birthweight and gestational age in antepartum stillbirths. Br J Obstet Gynaecol 105 (1998) 524-530
9. Yanney M., and Marlow N. Paediatric consequences of fetal growth restriction. Semin Fetal Neonatal Med 9 (2004) 411-418
10. Barker D.J., Eriksson J.G., Forsen T., et al. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 31 (2002) 1235-1239
11. Hadlock F.P., Deter R.L., Harrist R.B., et al. Estimating fetal age: computer-assisted analysis of multiple fetal growth parameters. Radiology 152 (1984) 497-501
12. Hutcheon J.A., and Platt R.W. The missing data problem in birth weight percentiles and thresholds for "small-for-gestational-age". Am J Epidemiol 167 (2008) 786-792
13. Health Council of the Netherlands. Preconception care: a good beginning. The Hague: 2007.
14. Centres for Disease Control and Prevention. Recommendations to improve preconception health and health care - United States: a report of the CDC/ATSDR Preconception Care Work Group and the Select Panel on Preconception Care. 2006.
15. Qin X., Wu Y., Wang W., et al. Low organic solvent exposure and combined maternal-infant gene polymorphisms affect gestational age. Occup Environ Med 65 (2008) 482-487
16. Wang X., Zuckerman B., Pearson C., et al. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 287 (2002) 195-202
17. Hodnett E.D., and Fredericks S. Support during pregnancy for women at increased risk of low birthweight babies. Cochrane Database Syst Rev 3 (2003) CD000198
18. Gortzak-Uzan L., Hallak M., Press F., et al. Teenage pregnancy: risk factors for adverse perinatal outcome. J Matern Fetal Med 10 (2001) 393-397
19. Joseph K.S., Allen A.C., Dodds L., et al. The perinatal effects of delayed childbearing. Obstet Gynecol 105 (2005) 1410-1418
20. Laws P.J., Abeywardana S., Walker J., et al. Australia's mothers and babies (2005), AIHW National Perinatal Statistics Unit 2007, Sydney
21. Schieve L.A., Cohen B., Nannini A., et al. A population-based study of maternal and perinatal outcomes associated with assisted reproductive technology in Massachusetts. Matern Child Health J 11 (2007) 517-525
22. Wang Y.A., Dean J.H., Badgery-Parker T., et al. Assisted reproduction technology in Australia and New Zealand 2006 (2008), AIHW National Perinatal Statistics Unit, Sydney
23. Adamson L, Brown W, Byles J, et al. Women's weight: Findings from the Australian Longitudinal Study on Women's Health. Report prepared for Australian Government Department of Health & Ageing, June 2007.
24. Australian Institute of Health and Welfare. Health, wellbeing and bodyweight: characteristics of overweight and obesity in Australia, 2001. Bulletin No.13: AIHW; 2001.
25. Callaway L.K., Prins J.B., Chang A.M., et al. The prevalence and impact of overweight and obesity in an Australian obstetric population. Med J Aust 184 (2006) 56-59
26. Doherty D.A., Magann E.F., Francis J., et al. Pre-pregnancy body mass index and pregnancy outcomes. Int J Gynaecol Obstet 95 (2006) 242-247
27. National Research Council and Institute of Medicine. Influence of pregnancy weight on maternal and child health - workshop report. Washington, DC 2007.
28. Cedergren M. Effects of gestational weight gain and body mass index on obstetric outcome in Sweden. Int J Gynaecol Obstet 93 (2006) 269-274
29. Cedergren M.I. Optimal gestational weight gain for body mass index categories. Obstet Gynecol 110 (2007) 759-764
30. Kramer M.S., and Kakuma R. Energy and protein intake in pregnancy. Cochrane Database Syst Rev 4 (2003) CD000032
31. Ceesay S.M., Prentice A.M., Cole T.J., et al. Effects on birth weight and perinatal mortality of maternal dietary supplements in rural Gambia: 5 year randomised controlled trial. BMJ 315 (1997) 786-790
32. Haider B.A., and Bhutta Z.A. Multiple-micronutrient supplementation for women during pregnancy. Cochrane Database Syst Rev 4 (2006) CD004905
33. Williams M.D., and Wheby M.S. Anemia in pregnancy. Med Clin North Am 76 (1992) 631-647
34. Reveiz L., Gyte G.M., and Cuervo L.G. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev 2 (2007) CD003094
35. Pena-Rosas J.P., and Viteri F.E. Effects of routine oral iron supplementation with or without folic acid for women during pregnancy. Cochrane Database Syst Rev 3 (2006) CD004736
36. Christian P., Khatry S.K., Katz J., et al. Effects of alternative maternal micronutrient supplements on low birth weight in rural Nepal: double blind randomised community trial. BMJ 326 (2003) 571
37. Mahomed K., Bhutta Z., and Middleton P. Zinc supplementation for improving pregnancy and infant outcome. Cochrane Database Syst Rev 2 (2007) CD000230
38. Makrides M., and Crowther C.A. Magnesium supplementation in pregnancy. Cochrane Database Syst Rev 4 (2001) CD000937
39. Thaver D., Saeed M.A., and Bhutta Z.A. Pyridoxine (vitamin B6) supplementation in pregnancy. Cochrane Database Syst Rev 2 (2006) CD000179
40. WHO. Reaching optimal iodine nutrition in pregnant and lactating women and young children: joint statement by the World Health Organization and the United Nations Children's Fund; 2007.
41. Christian P., Darmstadt G.L., Wu L., et al. The effect of maternal micronutrient supplementation on early neonatal morbidity in rural Nepal: a randomised, controlled, community trial. Arch Dis Child 93 (2008) 660-664
42. WHO. Promoting optimal fetal development: report of a technical consultation. Geneva, Switzerland: 2003.
43. Wills R.A., and Coory M.D. Effect of smoking among indigenous and non-indigenous mothers on preterm birth and full-term low birthweight. Med J Aust 189 (2008) 490-494
44. Andres R.L., and Day M.C. Perinatal complications associated with maternal tobacco use. Semin Neonatol 5 (2000) 231-241
45. Lumley J., Oliver S.S., Chamberlain C., et al. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 4 (2004) CD001055
46. Mills J.L., Graubard B.I., Harley E.E., et al. Maternal alcohol consumption and birth weight. How much drinking during pregnancy is safe?. JAMA 252 (1984) 1875-1879
47. NHMRC. Australian alcohol guidelines: health risks and benefits. National Health and Medical Research Council of Australia 2001.
48. Doggett C., Burrett S., and Osborn D.A. Home visits during pregnancy and after birth for women with an alcohol or drug problem. Cochrane Database Syst Rev 4 (2005) CD004456
49. Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study. BMJ 337 (2008) 2332
50. Clapp III J.F. Exercise during pregnancy. A clinical update. Clin Sports Med 19 (2000) 273-286
51. Kramer M.S., and McDonald S.W. Aerobic exercise for women during pregnancy. Cochrane Database Syst Rev 3 (2006) CD000180
52. WHO. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access: recommendations for a public health approach: HIV/AIDS Programme 2006.
53. WHO. Guidance on global scale-up of the prevention of mother to child transmission of HIV: towards universal access for women, infants and young children and eliminating HIV and AIDS among children/Inter-Agency Task Team on Prevention of HIV Infection in Pregnant Women, Mothers and their Children. 2007.
54. Giaquinto C., Rampon O., and De Rossi A. Antiretroviral therapy for prevention of mother-to-child HIV transmission: focus on single-dose nevirapine. Clin Drug Investig 26 (2006) 611-627
55. Garner P., and Gulmezoglu A.M. Drugs for preventing malaria in pregnant women. Cochrane Database Syst Rev 4 (2006) 18 CD000169
56. WHO. Protecting vulnerable groups in malaria-endemic areas in Africa through accelerated deployment of insecticide-treated nets. WHO UNICEF Joint Statement 2005.
57. Gamble C., Ekwaru J.P., and Ter Kuile F.O. Insecticide-treated nets for preventing malaria in pregnancy. Cochrane Database Syst Rev 2 (2006) CD003755
58. Alfirevic Z., Roberts D., and Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 101 (2002) 6-14
59. Empson M., Lassere M., Craig J., et al. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2 (2005) CD002859
60. Ottawa Health Research Institute. Thrombophilia in Pregnancy Prophylaxis Study (TIPPS). [cited; Available from:. http://www.ohri.ca/programs/clinical_epidemiology/Thrombosis_Group/studies/TIPPS.asp
61. ASSHP. The detection, investigation and management of hypertension in pregnancy: executive summary. 2000.
62. Duley L., Henderson-Smart D.J., Meher S., et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2 (2007) CD004659
63. Askie L.M., Duley L., Henderson-Smart D.J., et al. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369 (2007) 1791-1798
64. Wang Y., and Walsh S.W. Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic pregnancies. J Soc Gynecol Investig 3 (1996) 179-184
65. Diplock A.T. The Leon Golberg Memorial Lecture. Antioxidants and disease prevention. Food Chem Toxicol 34 (1996) 1013-1020
66. Rumbold A., Duley L., Crowther C.A., et al. Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev 1 (2008) CD004227
67. Hofmeyr G.J., Atallah A.N., and Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 3 (2006) CD001059
68. Abalos E., Duley L., Steyn D.W., et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 1 (2007) CD002252
69. Magee L.A., and Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 3 (2003) CD002863
70. The Centre for Mother Infant and Child Research. Control of Hypertension In Pregnancy Study (CHIPS). [cited; Available from:. http://www.utoronto.ca/cmicr/chips/index.html
71. Churchill D., and Duley L. Interventionist versus expectant care for severe pre-eclampsia before term. Cochrane Database Syst Rev 3 (2002) CD003106
72. Weiner C.P. Pathogenesis, evaluation, and potential treatments for severe, early onset growth retardation. Semin Perinatol 13 4 (1989 Aug) 320-327
73. Lumley J., Watson L., Watson M., et al. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev 3 (2001) CD001056
74. Australasian society of infectious diseases. Management of perinatal infections. 2006.
75. Ornoy A. Fetal effects of primary and non-primary cytomegalovirus infection in pregnancy: are we close to prevention?. Isr Med Assoc J 9 (2007) 398-401
76. Houlton M.C., Marivate M., and Philpott R.H. The prediction of fetal growth retardation in twin pregnancy. Br J Obstet Gynaecol 88 (1981) 264-273
77. Rao A., Sairam S., and Shehata H. Obstetric complications of twin pregnancies. Best Pract Res Clin Obstet Gynaecol 18 (2004) 557-576
78. Cheung A.P. Assisted reproductive technology: both sides now. J Reprod Med 51 (2006) 283-292
79. Gulmezoglu A.M., and Hofmeyr G.J. Bed rest in hospital for suspected impaired fetal growth. Cochrane Database Syst Rev 2 (2000) CD000034
80. Gulmezoglu A.M., and Hofmeyr G.J. Calcium channel blockers for potential impaired fetal growth. Cochrane Database Syst Rev 2 (2000) CD000049
81. Say L., Gulmezoglu A.M., and Hofmeyr G.J. Maternal nutrient supplementation for suspected impaired fetal growth. Cochrane Database Syst Rev 1 (2003) CD000148
82. Harding J.E., Owens J.A., and Robinson J.S. Should we try to supplement the growth retarded fetus? A cautionary tale. Br J Obstet Gynaecol 99 (1992) 707-709
83. Say L., Gulmezoglu A.M., and Hofmeyr G.J. Maternal oxygen administration for suspected impaired fetal growth. Cochrane Database Syst Rev 1 (2003) CD000137
84. A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation. BJOG 110 (2003) 27-32
85. Boers K.E., Bijlenga D., Mol B.W., et al. Disproportionate intrauterine growth intervention trial at term: DIGITAT. BMC Pregnancy Childbirth 7 (2007) 12
86. Roberts D., and Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 3 (2006) CD004454
87. Crowther C.A., Doyle L.W., Haslam R.R., et al. Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. N Engl J Med 357 (2007) 1179-1189
88. Doyle L.W., Crowther C.A., Middleton P., et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 3 (2007) CD004661
89. Rouse D.J., Hirtz D.G., Thom E., et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 359 (2008) 895-905